Morphosys AG - ADR
NASDAQ:MOR 3:59:40 PM EDT
| Market Cap (Intraday) | 3.25B |
| Current PE | 50.72 |
| Forward PE | 124.1 |
| 2yr Forward PE | N/A |
| 10-Day MA | $25.68 |
| 50-Day MA | $28.18 |
| 200-Day MA | $29.81 |
MorphoSys AG Stock, NASDAQ:MOR
Semmelweisstrasse 7, Semmelweisstrasse 7, Planegg, Bayern (Bavaria) 82152
Germany
Phone: +49.89.89927.0
Number of Employees: 426
Description
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.